She developed the first effective injectable treatment for leprosy at twenty-three. She was Black. She was a woman. She was working at a small territorial college in a U.S. territory that had been illegally annexed within recent memory. She died at twenty-four before publishing her findings. The supervisor who had access to her work published it without her name. The physician who had brought her the problem named her work correctly in 1922 and was largely ignored. The institutional memory that might have preserved her name did not.

 

None of this is a story about one man’s villainy or one institution’s deliberate malice. It is a story about how ordinary systems produce extraordinary injustices, how scientific credit flows to the people positioned to publish, and how the accumulated weight of small structural disadvantages can erase someone who was entirely capable of protecting her own record if she had lived.

 

She did not live. She left behind a method that worked, that was used, and that helped patients recover from a disease that had confined generations of people to involuntary exile. The method worked for three decades before a better treatment replaced it. The patients who recovered using her preparation were real people who returned to real lives. That those lives were enabled by Alice Ball’s chemistry — by the specific work of a twenty-three-year-old Black chemist in a Honolulu laboratory in 1915 — is both a fact of history and a reason to know her name.

 

 

—

 

## The Daguerreotype and the Laboratory

ADVERTISEMENT
Advertisement
Share.